FDA Policy/General
Federal Judge Rejects FDA Bid to Dismiss Niagen Challenge
A federal judge has denied FDA's motion to dismiss a lawsuit challenging the agency's decision to allow nicotinamide mononucleotide (NMN), an ingredient used in anti-aging products, to be marketed as a dietary supplement rather than regulated as a drug. In an 11/19 memorandum opinion,